Compare Smith & Nephew plc (SNN) vs TKO Group Holdings Inc (TKO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs TKO Group Holdings Inc — how do they compare? Smith & Nephew plc trades at $27.24 (market cap $11.10B), while TKO Group Holdings Inc trades at $178.01 (market cap $13.28B). The key difference: TKO Group Holdings Inc is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and TKO Group Holdings Inc for 30 Days on average.
| SNN | TKO | |
|---|---|---|
Market Cap | $11.10B | $13.28B |
Volume | 1,051,703 | 857,653 |
Sector | Health | Media |
52-Week High | $37.17 | $224.96 |
52-Week Low | $26.42 | $175.58 |
Typical Hold Time | 121 Days | 30 Days |
Enterprise Value | $14.13B | $17.64B |
Dividend Yield | 2.95% | 1.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
TKO trades at $178.01, down 0.35% on the day, near its 52-week low of $174.58 (Defense World, 2026-10-02). The stock is technically bearish with mixed earnings history, including a Q2 2026 EPS miss. Revenue grew to $5.3B in 2026 with a net profit margin of 4.32%. A quarterly dividend of $0.79 is scheduled for payment on September 30, 2026.
Wall Street maintains a strong buy consensus (89% buy ratings) with a $227 price target, suggesting significant upside. Key risks include earnings volatility and competitive pressures in sports entertainment. Positive catalysts are media rights deals and live event momentum, but the stock faces near-term technical headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →
